A detailed history of Mckinley Capital Management LLC transactions in Novartis Ag stock. As of the latest transaction made, Mckinley Capital Management LLC holds 23,015 shares of NVS stock, worth $2.39 Million. This represents 0.44% of its overall portfolio holdings.

Number of Shares
23,015
Previous 23,069 0.23%
Holding current value
$2.39 Million
Previous $2.23 Million 9.82%
% of portfolio
0.44%
Previous 0.28%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 12, 2024

SELL
$92.57 - $107.37 $4,998 - $5,797
-54 Reduced 0.23%
23,015 $2.45 Million
Q1 2024

May 01, 2024

BUY
$95.27 - $108.47 $565,046 - $643,335
5,931 Added 34.61%
23,069 $2.23 Million
Q4 2023

Feb 09, 2024

SELL
$92.27 - $101.54 $35,985 - $39,600
-390 Reduced 2.23%
17,138 $1.73 Million
Q3 2023

Nov 13, 2023

BUY
$94.73 - $105.13 $124,285 - $137,930
1,312 Added 8.09%
17,528 $1.79 Million
Q2 2023

Aug 09, 2023

SELL
$92.52 - $104.91 $24,795 - $28,115
-268 Reduced 1.63%
16,216 $1.64 Million
Q1 2023

May 11, 2023

SELL
$80.03 - $92.81 $25,449 - $29,513
-318 Reduced 1.89%
16,484 $1.52 Million
Q4 2022

Jan 18, 2023

SELL
$75.55 - $92.52 $8,839 - $10,824
-117 Reduced 0.69%
16,802 $0
Q3 2022

Nov 14, 2022

SELL
$74.61 - $87.26 $1,790 - $2,094
-24 Reduced 0.14%
16,919 $1.29 Million
Q2 2022

Aug 05, 2022

SELL
$80.52 - $93.75 $15,137 - $17,625
-188 Reduced 1.1%
16,943 $1.43 Million
Q1 2022

Apr 29, 2022

SELL
$80.11 - $90.62 $65,770 - $74,399
-821 Reduced 4.57%
17,131 $1.5 Million
Q4 2021

Feb 14, 2022

SELL
$79.7 - $88.13 $50,848 - $56,226
-638 Reduced 3.43%
17,952 $1.57 Million
Q3 2021

Nov 15, 2021

SELL
$81.78 - $95.14 $59,699 - $69,452
-730 Reduced 3.78%
18,590 $1.52 Million
Q2 2021

Aug 03, 2021

SELL
$85.24 - $94.15 $27,532 - $30,410
-323 Reduced 1.64%
19,320 $1.76 Million
Q1 2021

Apr 21, 2021

SELL
$83.5 - $98.47 $18,704 - $22,057
-224 Reduced 1.13%
19,643 $1.68 Million
Q4 2020

Feb 10, 2021

SELL
$78.07 - $94.43 $42,626 - $51,558
-546 Reduced 2.67%
19,867 $1.88 Million
Q3 2020

Nov 02, 2020

SELL
$82.14 - $91.0 $74,418 - $82,446
-906 Reduced 4.25%
20,413 $1.78 Million
Q2 2020

Jul 27, 2020

SELL
$80.93 - $91.1 $127,060 - $143,027
-1,570 Reduced 6.86%
21,319 $1.86 Million
Q1 2020

May 05, 2020

SELL
$70.67 - $99.01 $50,317 - $70,495
-712 Reduced 3.02%
22,889 $1.89 Million
Q4 2019

Jan 23, 2020

BUY
$84.35 - $95.37 $1.2 Million - $1.35 Million
14,188 Added 150.73%
23,601 $2.24 Million
Q3 2019

Nov 12, 2019

SELL
$85.54 - $94.26 $19,417 - $21,397
-227 Reduced 2.35%
9,413 $818,000
Q2 2019

Aug 07, 2019

SELL
$75.4 - $92.8 $159,018 - $195,715
-2,109 Reduced 17.95%
9,640 $880,000
Q1 2019

May 02, 2019

SELL
$75.32 - $86.15 $51,895 - $59,357
-689 Reduced 5.54%
11,749 $1.13 Million
Q4 2018

Feb 11, 2019

BUY
$73.66 - $82.02 $916,183 - $1.02 Million
12,438 New
12,438 $1.07 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mckinley Capital Management LLC Portfolio

Follow Mckinley Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mckinley Capital Management LLC , based on Form 13F filings with the SEC.

News

Stay updated on Mckinley Capital Management LLC with notifications on news.